Hamartoma

Confirming the disease name

• Disease name: Hamartoma (과오종) — a medically used term referring to a generally benign localized lesion formed by an abnormal excess and mixture of normally mature cells.

1) Disease description (causes and symptoms)

• Cause/pathophysiology: During embryonic or developmental processes, cells and connective tissues that normally exist in the affected organ become excessive or abnormally arranged, forming a structure in which “the tissue components are normal, but the architecture is disorganized.” The exact mechanism of development is not clear. In general, unlike true malignant neoplasms, the cells are mature and abnormal proliferation is limited.
• Main symptoms: Primarily vary depending on the site and size of the lesion.
  • Lung (pulmonary hamartoma): Often an incidentally discovered solitary nodule without symptoms (coin-shaped opacity). Cough, hemoptysis, or chest pain may occur rarely.
  • Stomach·colon (hamartomatous polyp): Bleeding, abdominal pain, intestinal obstruction (when large), and possible intussusception.
  • Breast·skin·liver·kidney, etc.: A palpable lump, cosmetic concerns, or pressure symptoms.
  • Brain·hypothalamus (such as hypothalamic hamartoma): Neurological or endocrine symptoms such as seizures (epilepsy) and precocious puberty.
• Clinical characteristics: Most have a benign course and generally do not progress to cancer (however, cancer-risk assessment is needed for some hamartomas/polyp groups associated with specific hereditary syndromes).

2) Treatment methods

• General principles: Observation (regular follow-up examinations) is generally the standard. Whether treatment is needed is determined based on symptoms, size, location, and diagnostic uncertainty (whether malignancy is suspected).
• Diagnostic/therapeutic procedures:
  • Imaging tests: X-ray, CT, MRI, ultrasound, etc., to assess the location, size, and composition (fat, cartilage, blood vessels, etc.).
  • Biopsy: Pathological confirmation by core-needle biopsy or excisional biopsy.
  • Surgery/procedures: Local excision (or endoscopic removal, wedge resection, etc.) may be performed when symptoms are present, when the lesion compresses nearby organs or causes bleeding or functional impairment, or for cosmetic reasons.
  • Endoscopic treatment: Mucosal polyp-type hamartomas in the stomach or colon may be removed endoscopically by polypectomy.
• Drug treatment: Separate anticancer drug treatment is not necessary. Adjunctive treatment (pain control, treatment of infection, etc.) is provided according to symptoms.
• Lifestyle management and precautions:
  • Regular imaging and clinical follow-up (the interval is determined based on the characteristics of the lesion).
  • Consult a healthcare professional immediately if there is an increase in size, pain, bleeding, or functional impairment (shortness of breath, indigestion, etc.).
  • If biopsy results are unclear or malignancy is suspected, additional testing (specialized imaging or repeat sampling) is needed.
• Possible complications:
  • Pressure symptoms caused by the mass (shortness of breath, intestinal obstruction, etc.), bleeding, local infection, and recurrence in cases of incomplete excision.
  • At some sites (e.g., the hypothalamus), neurological or endocrine complications (seizures, hormonal abnormalities) may occur.
• Prognosis: Generally favorable, with a low recurrence rate after complete excision.

3) Checkpoints before an outpatient visit (including items to bring and sample questions)

• Items/materials to bring:
  • A list of currently used medications (including prescription drugs, over-the-counter drugs, and herbal medicines) and a history of allergies.
  • Previous test results (imaging reports, CDs/films, previous pathology reports, etc.) — original images or reports if possible.
  • A record of when symptoms began and how they have progressed (changes in size, pain, bleeding, shortness of breath, etc.).
  • Family history (hereditary tumors, polyposis syndromes, etc.) and a history of previous surgery or hospitalization.
  • Menstrual status and possibility of pregnancy (for women).
• Information to tell the healthcare professional in advance during the visit:
  • Sudden changes in symptoms (acute pain, hemoptysis, severe bleeding, etc.).
  • Whether anticoagulants or antiplatelet drugs are being taken (important before a procedure or biopsy).
• Examples of materials to show the healthcare professional at the outpatient visit:
  • Recently performed imaging (CT/MRI/X-ray), previous pathology reports, and a medication list.

4) Examples of general questions to ask the doctor

• How likely is it that this lesion is malignant? Is a biopsy necessary?
• What should the interval between follow-up examinations be (e.g., 6 months, 1 year)?
• What criteria do you use to recommend surgery (or endoscopic removal)?
• What are the common side effects and complications after treatment or a procedure?
• Are there any lifestyle precautions (exercise, diet, medications, etc.)?

5) Examples of disease-specific questions

• Regarding pulmonary hamartoma (nodule): "If the nodule observed on the CT grows beyond a certain size, would you recommend surgical removal? What are the follow-up interval and criteria?"
• Regarding gastric·colonic hamartomatous polyps: "Could this polyp be associated with a hereditary polyposis syndrome? Depending on the family history, would genetic testing or screening of family members be necessary?"

(Note) Because the lesion’s exact location, size, imaging findings, medical history, and family history are important for additional evaluation or treatment decisions, it is recommended that you bring the relevant materials and consult a specialist during the outpatient visit.